RxSight, Inc.
RxSight, Inc. scores highest on Torque (64) and lowest on Nitro (24). Its PosiPenta is 45.37 out of 100, around the middle of similar companies.
On the Penta Grid this week, RxSight, Inc. is Grid #373 of 837 in the Healthcare sector in United States, and Grid #2,381 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| RxSight, Inc. | 45.37 | 43 | 48 | 24 | 64 | 47 |
| Glass House Brands Inc. | 41.38 | 16 | 71 | 19 | 47 | 55 |
| Protalix BioTherapeutics, Inc. | 66.10 | 62 | 83 | 82 | 71 | 33 |
| Alector, Inc. | 34.46 | 0 | 46 | 57 | 12 | 57 |
| Pyxis Oncology, Inc. | 27.64 | 3 | 39 | 35 | 15 | 47 |
| Pro-Dex, Inc. | 64.12 | 54 | 54 | 79 | 64 | 70 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.96 |
| P/B ratio | 0.71 |
EEarnings
| Trailing EPS | ₹-107.97 |
| Forward EPS | ₹-64.73 |
NNitro
| Price | 427.16 |
| 52-week high | 1252.13 |
| 52-week low | 416.75 |
| Fall from 52-week high | 65.9% |
TTorque
| Return on equity (ROE) | -17.34% |
| Debt-to-equity | 0.04 |
AAnchor
| Beta (price swings) | 1.14 |
| Market cap | ₹1,776 Cr |
| Insider holding | 6.57% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is RxSight, Inc.'s PosiPenta score?
RxSight, Inc.'s PosiPenta is 45.37 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does RxSight, Inc. stand on the Penta Grid?
On the Penta Grid this week, RxSight, Inc. is Grid #373 of 837 in the Healthcare sector in United States, and Grid #2,381 of 4,000 in United States.
Which PosiPenta pillar is strongest for RxSight, Inc.?
Torque (durability), with a score of 64 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for RxSight, Inc.?
Nitro (momentum), with a score of 24 out of 100: weaker than most similar companies.
Has RxSight, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.08 points, from 42.29 to 45.37.
PositoAI is for research and education only and is not investment advice.